3Chopt Investment Partners LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

3Chopt Investment Partners LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 856 shares of the company’s stock, valued at approximately $275,000.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. CreativeOne Wealth LLC purchased a new position in HCA Healthcare during the first quarter valued at $231,000. New Mexico Educational Retirement Board increased its holdings in shares of HCA Healthcare by 29.9% in the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new position in HCA Healthcare during the first quarter valued at approximately $566,000. Teachers Retirement System of The State of Kentucky increased its stake in HCA Healthcare by 15.6% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after acquiring an additional 26,919 shares during the last quarter. Finally, Brave Warrior Advisors LLC boosted its position in shares of HCA Healthcare by 182.1% during the 4th quarter. Brave Warrior Advisors LLC now owns 3,873 shares of the company’s stock valued at $1,048,000 after acquiring an additional 2,500 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Down 0.2 %

Shares of HCA Healthcare stock opened at $405.45 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $409.42. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The stock has a market cap of $106.19 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.52 and a beta of 1.67. The firm’s 50-day moving average is $381.85 and its two-hundred day moving average is $344.10.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.29 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock worth $6,407,273 over the last three months. Corporate insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on HCA. Barclays increased their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Oppenheimer boosted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial lifted their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Leerink Partners raised their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.